SUMMARY Impaired glucose tolerance, assessed by a raised glycated haemoglobin (HbAj) concentration, was found in 24 (39%) out of 61 patients with cystic fibrosis with an age range of 1-23 years. No correlation between age and HbA1 concentration was found indicating that factors other than progressive pancreatic fibrosis may be important in the aetiology. HLA typing, islet cell antibodies, and autoantibody screen were completed. Eighteen (75%) out of 24 patients with cystic fibrosis who had an impaired glucose tolerance had HLA-DR3 or HLA-DR4 antigens compared with 23 (62%) out of 37 patients with normal glucose tolerance. Islet cell antibodies were present in seven (15%) out of 46 patients with cystic fibrosis; the prevalence in a normal population is 0-5%. Five (25%) of the 20 patients with a raised HbAj concentration were positive for islet cell antibodies compared with two (8%) out of the 26 with normal glucose tolerance. Six (86%) out of seven patients who were positive for islet cell antibodies had HLA-DR3 or HLA-DR4 antigens. There was no general autoantibody production. Islet cell antibodies may play a part in the development of glucose intolerance in some patients with cystic fibrosis by being produced in those who are genetically predisposed as part of an immune response to damaged pancreatic tissue.
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The incidence of insulin dependent diabetes in patients with cystic fibrosis is reported to be 1_10%1-3; this is many times the incidence in a normal population. 4 Glucose intolerance occurs in 8-75%. Early studies suggested that glucose intolerance develops in patients with cystic fibrosis secondary to pancreatic damage after exocrine pancreatic disease rather than in association with juvenile onset diabetes. Increasing disruption of islet cells without decrease in islet cell number was found with increasing age, as a result of progressive pancreatic fibrosis.5 It was proposed that the islet cell disruption led to the delayed and impaired release of insulin, leading to glucose intolerance. Immunohistochemical techniques, however, have shown a reduced islet and ,B cell number in patients with cystic fibrosis who have insulin dependent diabetes.2 3 6 In addition, a lack of correlation between glucose intolerance, age, and Shwachman score has been reported.2 7 These findings suggest that aetiological factors other than progressive pancreatic fibrosis may contribute to the development of glucose intolerance and insulin dependence.
The increased familial incidence and the association with HLA genes B8, B15, and in particular DR3 and DR4, indicates that genetic factors are important in the aetiology of type I insulin dependent diabetes. Using the same conditions for the pancreas, reagent, and incubation, the putative islet cell antibody standards currently being assessed by the immunology and diabetes workshops gave end point titres of 32 when tested 'blind' on two occasions.28 Samples were read by two independent observers and the interassay reproducibility was one doubling dilution. Weakly positive reactions were confirmed on several human blood group 0 pancreases by different observers.
The autoantibody screening included gastric parietal cell antibody and a variety of non-organ specific antibodies-for example, antinuclear and mitochondrial.29 30 Thyroglobulin and thyroid microsomal antibodies were determined by passive haemagglutination using commercial kits (Wellcome, thymune).
Ethical committee approval for the study was given and parental consent obtained.
Results

CLINICAL ANALYSIS
On entry into the study, 21 of the 61 patients with cystic fibrosis were found to have a raised HbA1 concentration: mean 10-6%, range 9*1-17-5%. Dur 
